Entera Bio Ltd. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by Entera Bio Ltd., a foreign private issuer, on January 22, 2019. The filing serves to incorporate by reference a press release issued on the same date. The document also references unaudited condensed consolidated interim financial information and management discussion for the period ended September 30, 2018, as Exhibits 99.1 and 99.2.
Key Financial Metrics
The provided text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The filing text indicates that financial data for the period ended September 30, 2018, is located in the attached exhibits (99.1 and 99.2) rather than in the cover letter text itself.
Material Changes
The filing text does not explicitly detail material changes versus prior periods. It directs readers to the attached press release (Exhibit 99.3) and the Management's Discussion and Analysis (Exhibit 99.2) for operational and financial updates.
Guidance, Outlook, and Risks
Specific guidance, outlook, management commentary, risks, contingencies, or unusual items are not detailed in the provided cover text. These elements are contained within the incorporated press release and financial exhibits.
Investor Verification Checklist
- Review Exhibit 99.3 (Press Release dated January 22, 2019) for the primary announcement driving this filing.
- Examine Exhibit 99.1 for the unaudited condensed consolidated interim financial statements for the period ended September 30, 2018.
- Analyze Exhibit 99.2 for Management's Discussion and Analysis regarding financial condition and results of operations.
- Verify the company's cash position and burn rate given the lack of revenue data in the cover text.